Guangdong Runke Bioengineering Co., Ltd.（广东润科生物工程股份有限公司）is a leading biotechnology enterprise specializing in the research, development, and large-scale production of high-quality microalgae-derived nutritional oils and powders. Headquartered in Shantou, Guangdong Province, China, the company focuses on delivering safe, traceable, and highly bioavailable sources of DHA (docosahexaenoic acid) and ARA (arachidonic acid) for use in infant nutrition, dietary supplements, and functional foods.
Company Background
Established with a mission to provide sustainable and high-purity sources of essential fatty acids, Guangdong Runke Bioengineering has developed proprietary fermentation and purification technologies based on microalgae and fungal strains. With more than a decade of experience in the bioengineering sector, Runke has become one of China’s top suppliers of DHA and ARA ingredients for infant formula manufacturers and global nutritional brands.
Core Business
The company’s core business lies in microbial fermentation, extraction, and refinement of polyunsaturated fatty acids (PUFAs), specifically:
- DHA derived from Crypthecodinium cohnii (microalgae)
- ARA derived from Mortierella alpina (fungus)
These oils and powders are formulated for applications in infant formula, maternal supplements, elderly nutrition, and general functional foods.
Product Offerings
Nutritional Lipids:
- DHA Oil (35%+, 40%+ DHA content): Algal-sourced, odorless, and stable; used in infant formula and dietary supplements
- ARA Oil (40%+ ARA content): High-purity fungal ARA oil used in early-stage brain and immune system development
Encapsulated Powders:
- DHA Powder: Microencapsulated DHA for easy formulation into powdered supplements, beverages, and dairy applications
- ARA Powder: Used in dry blends for infant and pediatric nutrition products
All products are strictly manufactured to meet national and international food safety and nutritional standards.
Specialization and USP
Guangdong Runke is distinguished by:
- End-to-end vertically integrated production from strain cultivation to final ingredient
- Proprietary encapsulation technology enhancing oxidative stability and shelf life
- Clean, plant-based, and allergen-free DHA and ARA sources ideal for infant formulations
- Customization of concentration levels, carrier systems, and product specifications
The company’s DHA and ARA oils demonstrate oxidative stability indexes exceeding 20 hours (as measured by Rancimat), far above conventional market standards.
Financials
Though not publicly listed, industry sources and trade activity suggest:
- Estimated annual revenue: RMB 150–200 million (~USD 21–28 million)
- Over 75% of revenue generated from exports and bulk supply contracts
- Continuous investment in fermentation capacity and downstream processing capabilities
Shipment and Export Records
According to export data from ImportYeti and Volza:
- Over 300 documented export shipments from 2020 to 2024
- Major export destinations: Europe, North America, Southeast Asia, and the Middle East
- Key clients include infant formula manufacturers, contract supplement producers, and functional food developers
Target Market
Runke’s target market segments include:
- Infant Nutrition: DHA and ARA fortification for infant and toddler formulas
- Maternal Health: Prenatal and postnatal supplements
- Dietary Supplements: Capsules, gummies, and powders for general cognitive and immune support
- Medical Foods & Functional Nutrition: For elderly care and specific nutritional interventions
Capabilities
- Annual production capacity:
- DHA Oil: Over 800 tons
- ARA Oil: Over 500 tons
- DHA/ARA Powders: Over 400 tons
- Dedicated R&D center for strain development, lipid bioactivity studies, and formulation optimization
- Modern bioreactors, molecular filtration, and encapsulation lines
- Quality labs equipped with GC, HPLC, peroxide value analyzers, and shelf-life testing systems
Certifications and Compliance
- ISO 9001:2015 Certified
- ISO 22000: Food Safety Management System
- GMP Certified production lines
- Halal and Kosher certified ingredients
- Products comply with Chinese GB standards, EU Novel Food regulations, and US FDA GRAS status
Customer Testimonials
- “Runke’s DHA oil has become a key component in our infant formula range, offering consistent quality and excellent oxidative stability.” – Head of R&D, Infant Nutrition Company, Europe
- “We appreciate Runke’s ability to customize microencapsulated DHA powder to fit our functional beverage line. Their technical team is highly responsive.” – Director of Innovation, Functional Food Brand, Southeast Asia
Achievements
- Recognized as a Key National High-Tech Enterprise
- Holds 10+ invention patents related to lipid extraction and stabilization technologies
- Strategic partner in China’s Maternal and Infant Nutrition Innovation Alliance
- Participated in FIC (Food Ingredients China) and Vitafoods Europe with significant industry visibility
Guangdong Runke Bioengineering Co., Ltd. continues to advance marine and fungal-based biotechnology by delivering safe, traceable, and bioavailable lipid nutrition ingredients, powering the next generation of infant, maternal, and functional health products globally.
